Jonosteril Hd5

Magnesium chloride hexahydrate, potassium chloride, sodium chloride, calcium chloride dihydrate and glucose, the active ingredients in Jonosteril HD5, are an electrolyte solution presented as an intravenous solution for IV use. It provides fluid and electrolyte replacement in patients requiring resuscitation or correction of electrolyte deficiencies.

GNH USA supplies Jonosteril HD5 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Jonosteril HD5 is used in clinical situations that involve fluid loss or electrolyte disturbances. - Electrolyte replacement: restores sodium, potassium, calcium, magnesium and fluid balance in patients with deficits. - Fluid resuscitation: supplies essential ions and volume to support circulatory stability during shock or dehydration. - Correction of hypokalemia: raises low potassium levels to normal range. - Correction of hypomagnesemia: replenishes magnesium stores. - Correction of hypocalcemia: increases calcium concentration in the blood.

Common Side Effects: - Infusion site irritation: mild redness or discomfort at the catheter site. - Transient headache: short‑lasting headache during or after infusion. - Mild hypernatremia: slight increase in serum sodium levels. - Mild hyperkalemia: slight increase in serum potassium levels.

Serious or Rare Side Effects: - Severe electrolyte imbalance: dangerous shifts in sodium, potassium, calcium or magnesium. - Anaphylactic reaction: rare severe allergic response requiring immediate medical attention. - Cardiac arrhythmia: abnormal heart rhythm due to electrolyte disturbances.

Jonosteril HD5 should be administered with careful clinical monitoring. - Baseline assessment: evaluate patient electrolyte levels before infusion. - Cardiac risk: adjust infusion rate in patients with known heart disease. - Renal impairment: avoid rapid administration in patients with reduced kidney function. - Fluid status: monitor blood pressure and signs of fluid overload. - Storage: Store at controlled room temperature: keep in original container, protect from light and moisture.

Jonosteril HD5 may interact with other medications that affect electrolyte balance. Major Interactions (Avoid): - Calcium channel blockers: additive risk of hypercalcemia. - Potassium‑sparing diuretics: may precipitate hyperkalemia. - Concurrent IV electrolyte solutions: can cause severe electrolyte overload. Moderate Interactions (Monitor Closely): - Nephrotoxic drugs: require close monitoring of renal function. - High‑dose insulin therapy: may shift potassium intracellularly; monitor electrolytes.